1048. Double-Blind, Randomized, Placebo-Controlled Phase 2b Multicenter Trial of V160, a Replication-Defective Human Cytomegalovirus (CMV) Vaccine

por Das, Rituparna, Blazquez-Gamero, Daniel, Bernstein, David I, Gantt, Soren, Bautista, Oliver, Beck, Karen, Conlon, Anthony, Rosenbloom, Daniel, Wang, Dai, Ritter, Michael, Arnold, Beth, Annunziato, Paula, Russell, Kevin
Publicado 2021

Phase 1 Clinical Trial of a Replication-Defective Human Cytomegalovirus (CMV) Vaccine

por Adler, Stuart, Lewis, Nicole, Conlon, Anthony, Christiansen, Mark, Al-Ibrahim, Mohamed S, Rupp, Richard, Fu, Tong Ming, Bautista, Oliver, Tang, Huaping, Culp, Timothy, Das, Rituparna, Beck, Karen, Tamms, Gretchen, Musey, Luwy
Publicado 2017